Cardiovascular actions of thrombin receptor activation in vivo

Journal of Pharmacology and Experimental Therapeutics

Volumn 279, Issue 3, 1996, Pages 1365-1378

  Damiano, Bruce P ^a   Cheung, Wai Man ^a   Mitchell, John A ^a   Falotico, Robert ^a  

^a JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN; MEMBRANE RECEPTOR; PEPTIDE; SFLLRN; THROMBIN; THROMBIN RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL PRESSURE; ARTICLE; BLOOD VESSEL TONE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY CIRCUMFLEX BRANCH; CORONARY ARTERY CONSTRICTION; DOG; DOSE RESPONSE; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; HEART OUTPUT; HEART RATE; MALE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; ST SEGMENT; THROMBOCYTE FUNCTION; THROMBOGENESIS; VAGOTOMY; VASCULAR RESISTANCE;

ADENOSINE TRIPHOSPHATE; ANIMALS; BLOOD PRESSURE; CARDIAC OUTPUT; DOGS; ELECTROCARDIOGRAPHY; HEART RATE; INJECTIONS, INTRAVENOUS; MALE; PEPTIDE FRAGMENTS; PLATELET AGGREGATION; RECEPTORS, THROMBIN; VAGOTOMY;

EID: 0030438457     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. BARRON, K. W. AND BISHOP, V. S.: Reflex cardiovascular changes with veratridine in the conscious dog. Am. J. Physiol. 242: H810-H817, 1982.
2. BASHOUR, T. T.: Vasotonic myocardial ischemia. Am. Heart J. 122: 1701-1722, 1991.
3. BISHOP, V. S. AND PETERSON, D. F.: The circulatory influences of vagal afferents at rest and during coronary occlusion in conscious doga. Circ. Res. 43: 840-847, 1978.
4. COLERIDGE, H. M. AND COLERIDGE, J. C. G.: Cardiovascular afferents involved in regulation of peripheral vessels. Annu. Rev. Physiol. 42: 413-427, 1980.
5. CONNOLLY, T. M., CONDRA, C., FENG, D., COOK, J. J., STHANIERI, M. T., REILLY, C. F., NUTT, R. F. AND GOULD, R. J.: Species variability in platelet and other cellular responsiveness to thrombin receptor-derived peptides. Thromb. Haemost. 72: 627-633, 1994.
6. COUGHLIN, S. R., VU, T. H., HUNG, D. T. AND WHEATON, V. I.: Characterization of a functional thrombin receptor. Issues and opportunities. J. Clin. Invest. 89: 351-355, 1992.
7. DAMIANO, B. P., CHEUNG, W. M., MITCHELL, J. A. AND FALOTICO, R.: Thrombin receptor activating peptide alters coronary blood flow, left ventricular function and ECG in anesthetized dogs (Abstract). FASEB J. 9: A57 1995.
8. DAMIANO, B. P., MITCHELL, J. A., CHEUNG, W. M. AND FALOTICO, R.: Activation of vascular thrombin receptors mediates cardiac response to thrombin in isolated perfused guinea pig heart. Am. J. Physiol. 270: H1585-H1596, 1996.
9. DELIN, A., OLSSON, P. AND TEGER-NILSSON, A.: Vasodilation in the canine leg caused by intraarterial infusion of thrombin and tissue thromboplastin. Cardiovasc. Res. 1: 371-378, 1967.
10. DEMAY, J. G., CLAEYS, M. AND VANHOUTTE, P. M.: Endothelium-dependent inhibitory effects of acetylcholine, adenosine triphosphate, thrombin and arachidonic acid in the canine femoral artery. J. Pharmacol. Exp. Ther. 222: 166-173, 1982.
11. DERIAN, C. K, SANTULLI, R. J., TOMKO, K. A., HAERTLEIN, B. J. AND ANDRADE-GORDON, P.: Species differences in platelet responses to thrombin and SFLLRN. Receptor-mediated calcium mobilization and aggregation, and regulation by protein kinases. Thromb. Res. 78: 505-519, 1995.
12. DIHANICH, M., KASER, M., REINHARD, E., CUNNINGHAM, D. AND MONARD, D.: Prothrombin mRNA is expressed by cells of the nervous system. Neuron 6: 575-581, 1991.
13. EMORI, T., HIRATA, Y., IMAI, T., OHTA, K., KANNO, K., EGUCHI, S. AND MARUMO, F.: Cellular mechanism of thrombin on endothelin-1 biosynthesis and release in bovine endothelial cell. Biochem. Pharmacol. 44: 2409-2411, 1992.
14. FENTON, J. W., II: Regulation of thrombin generation and functions. Semin. Thromb. Hemost. 14: 234-240, 1988.
15. GARCIA, J. G. N.: Molecular mechanisms of thrombin-induced human and bovine endothelial cell activation. J. Lab. Clin. Med. 120: 513-519, 1992.
16. 2+ mobilization, barrier dysfunction, prostaglandin synthesis, and platelet-derived growth factor messenger RNA expression in cultured endothelium. J. Cell Physiol. 156: 541-549, 1993.
17. GLUSA, E.: Vascular effects of thrombin. Semin. Thromb. Hemost. 18: 296-304, 1992.
18. HAVER, V. M. AND NAMM, D. H.: Characterization of the thrombin-induced contraction of vascular smooth muscle. Blood Vessels 21: 53-63, 1984.
19. JANSSENS, W. J. AND VERHAEGHE, R. H.: Effect of thrombin on isolated canine blood vessels. Blood Vessels 19: 126-134, 1982.
20. KESSELS, H., WILLEMS, G. AND HEMKER, H. C.: Analysis of thrombin generation in plasma. Comput. Biol. Med. 24: 277-288, 1994.
21. KU, D. D.: Mechanism of thrombin-induced endothelium-dependent coronary vasodilation in dogs: role of its proteolytic enzymatic activity. J. Cardiovasc. Pharmacol. 8: 29-36, 1986.
22. KU, D. D.: Unmasking of thrombin vasoconstriction in isolated perfused dog hearts after intracoronary infusion of air embolus. J. Pharmacol. Exp. Ther. 243: 571-576, 1987.
23. KU, D. D. AND ZALESKI, J. K.: Receptor mechanism of thrombin-induced endothelium-dependent and endothelium-independent coronary vascular effects in dogs. J. Cardiovasc. Pharmacol. 22: 609-616, 1993.
24. LEW, W. Y. W., CHEN, Z., GUTH, B. AND COVELL, J. W.: Mechanisms of augmented segment shortening in nonischemic areas during acute ischemia of the canine left ventricle. Circ. Res. 56: 351-358, 1985.
25. LUM, H., ANDERSEN, T. T., FENTON, J. W., II. AND MALIK, A. B.: Thrombin receptor activation peptide induces pulmonary vasoconstriction. Am. J. Physiol. 266: C448-C454, 1994.
26. MALIK, A. B. AND FENTON, J. W., II.; Thrombin-mediated increase in vascular endothelial permeability. Semin. Thromb. Hemost. 18: 193-199, 1992.
27. MARK, A. L: The Bezold-Jarisch reflex revisited: Clinical implications of inhibitory reflexes originating in the heart. J. Am. Coll. Cardiol. 1: 90-102, 1983.
28. MARKWARDT, P., FRANKE, T., GLUSA, E. AND NILIUS, B.: Pharmacological modification of mechanical and electrical responses of from heart to thrombin. Naunyn Schmedebergs Arch. Pharmacol. 841: 341-46, 1990.
29. MCHOWAT, J. AND CORR, P. B.: Thrombin-induced release of lysophosphatidylcholine from endothelial cells. J. Biol. Chem. 268: 15605-15610, 1993.
30. MCNAMARA, C. A., SAREMBOCK, I. J., GIMPLE, L. W., FENTON II, J. W., COUGHLIN, S. R. AND OWENS, G. K.: Thrombin stimulates proliferation of cultured rat aortic smooth muscle cells by a proteolytically activated receptor. J. Clin. Invest. 91: 94-98, 1993.
31. MITCHELL, J. A., CHEUNG, W. L. AND DAMIANO, B. P.: Role of nitric oxide, endothelin and prostaglandins in the response to thrombin receptor activation in isolated guinea pig heart. FASEB J. 10: A41, 1996.
32. MURAMATSU, I., LANIYONU, A., MOORE, G. J. AND HOLLENBERO, M. D.: Vascular actions of thrombin receptor peptide. Can. J. Physiol. Pharmacol. 70: 996-1003, 1992.
33. NELKEN, N. A., SOIFER, S. J., O'KEEFE, J., VU, T. H., CHARO, I. F. AND COUGHLIN, S. R.: Thrombin receptor expression in normal and atherosclerotic human arteries. J. Clin. Invest. 90: 1614-1621, 1992.
34. OLSSON, P., SWEDENBORG, J. AND TEGER-NILSSON, A. C.: The role of adenine nucleotides in the peripheral vasodilating effect of thrombin. Acta Physiol. Scand. 76: 137-147, 1969,
35. PINHEIRO, J. M. B., ANDERSEN, T. T. AND MALIK, A. B.: Receptor mechanism of thrombin-mediated pulmonary vasodilation in neonates. Am. J. Physiol. 265: L355-L359, 1993.
36. 2+ mobilization. FEBS Lett. 288: 123-128, 1991.
37. SHANKAH, R., DE LA MOTTE, C. A., POPTIC, E. J. AND DICORLETO, P. E.: Thrombin receptor-activating peptides differentially stimulate platelet-derived growth factor production, monocytic cell adhesion, and E-selectin expression in human umbilical vein endothelial cells. J. Biol. Chem. 269: 13936-13941, 1994.
38. SHUMAN, M. A. AND MAJERUS, P. W.: The measurement of thrombin in clotting blood by radioimmunoassay. J. Clin. Invest. 68: 1249-1258, 1976.
39. STEINBERG, S. F., ROBINSON, R. B., LIEBERMAN, H. B., STERN, D. M. AND ROSEN, M. R.: Thrombin modulates phosphoinositide metabolism, cytosolic calcium, and impulse initiation in the heart. Circ. Res. 68: 1216-1229, 1991.
40. SWEDENBORG, J.: Thrombin-induced vasoconstriction in the pulmonary circulation. Scand. J. Clin. Lab. Invest. 27: 321-329, 1971.
41. TESFAMARIAM, B., ALLEN, G. T., NORMANDIN, D. AND ANTONACCIO, M. J.: Involvement of the tethered ligand receptor in thrombin-induced endothelium-mediated relaxations. Am. J. Physiol. 265: H1744-H1749, 1993.
42. THOREN, P.: Role of cardiac vagal c-fibers in cardiovascular control. Rev. Physiol. Biochem. Pharmacol. 86: 1-95, 1979.
43. VU, T. H., HUNG, D. T., WHEATON, V. I. AND COUGHLIN, S. R.: Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 64: 1057-1068, 1991.
44. WALZ, D. A., ANDERSON, G. F., CIAGLOWSKI, R. E., AIKEN, M. AND FENTON II, J. W.: Thrombin-elicited contractile responses of aortic smooth muscle. Proc. Soc. Exp. Biol. Med. 180: 518-526, 1985.
45. WHITE, R. P., SHIRASAWA, Y. AND ROBERTSON, J. T.: Comparison of responses elicited by alpha-thrombin in isolated canine basilar, coronary, mesenteric, and renal arteries. Blood Vess. 21: 12-22, 1984.
46. WILCOX, J. N., RODRIGUEZ, J., SUBRAMANIAM, R., OLLERENSHAW, J., ZHONG, C. Z., HAYZER, D. J., HORAIST, C., HANSON, S. R., LUMSDEN, A., SALAM, T. A., KELLY, A. B., HARKER, L. A. AND RUNGE, M.: Characterization of thrombin receptor expression during vascular lesion formation. Circ. Res. 78: 1029-1038, 1994.
47. XHU, W., MYERS, M. L., HARTLEY, C. J., ROBERTS, R. AND BOLLI, R.: Validation of a single crystal for measurement of transmural and epicardial thickening. Am. J. Physiol. 261: H1045-H1055, 1986.
48. ZUCKER, I. H.: Left ventricular receptors: physiological controllers or pathological curiosities?. Basic Res. Cardiol. 81: 539-557, 1986.